This report contains market size and forecasts of Diabetes Therapy and Drug Delivery in Global, including the following market information:
Global Diabetes Therapy and Drug Delivery Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Diabetes Therapy and Drug Delivery market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Diabetes Therapy and Drug Delivery companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Diabetes Therapy and Drug Delivery Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Diabetes Therapy and Drug Delivery Market Segment Percentages, By Type, 2020 (%)
Inhalable Insulin
Oral Insulin
Insulin Patches
CGM Systems
Artificial Pancreas
China Diabetes Therapy and Drug Delivery Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Diabetes Therapy and Drug Delivery Market Segment Percentages, By Application, 2020 (%)
Diagnostic/Clinics
ICUs
Home Healthcare
Global Diabetes Therapy and Drug Delivery Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Diabetes Therapy and Drug Delivery Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Total Diabetes Therapy and Drug Delivery Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Diabetes Therapy and Drug Delivery Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Abbott Laboratories
Medtronic
Sanofi
Novo Nordisk
MannKind
Enteris BioPharma
Dexcom
Senseonics Holding
Medtech
Johnson & Johnson
Synertech
Zosano Pharma
Relmada Therapeutics
Eli Lilly
Transdermal Specialties
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Diabetes Therapy and Drug Delivery Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Diabetes Therapy and Drug Delivery Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Diabetes Therapy and Drug Delivery Overall Market Size
2.1 Global Diabetes Therapy and Drug Delivery Market Size: 2021 VS 2027
2.2 Global Diabetes Therapy and Drug Delivery Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Diabetes Therapy and Drug Delivery Players in Global Market
3.2 Top Global Diabetes Therapy and Drug Delivery Companies Ranked by Revenue
3.3 Global Diabetes Therapy and Drug Delivery Revenue by Companies
3.4 Top 3 and Top 5 Diabetes Therapy and Drug Delivery Companies in Global Market, by Revenue in 2020
3.5 Global Companies Diabetes Therapy and Drug Delivery Product Type
3.6 Tier 1, Tier 2 and Tier 3 Diabetes Therapy and Drug Delivery Players in Global Market
3.6.1 List of Global Tier 1 Diabetes Therapy and Drug Delivery Companies
3.6.2 List of Global Tier 2 and Tier 3 Diabetes Therapy and Drug Delivery Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Diabetes Therapy and Drug Delivery Market Size Markets, 2021 & 2027
4.1.2 Inhalable Insulin
4.1.3 Oral Insulin
4.1.4 Insulin Patches
4.1.5 CGM Systems
4.1.6 Artificial Pancreas
4.2 By Type - Global Diabetes Therapy and Drug Delivery Revenue & Forecasts
4.2.1 By Type - Global Diabetes Therapy and Drug Delivery Revenue, 2016-2021
4.2.2 By Type - Global Diabetes Therapy and Drug Delivery Revenue, 2022-2027
4.2.3 By Type - Global Diabetes Therapy and Drug Delivery Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Diabetes Therapy and Drug Delivery Market Size, 2021 & 2027
5.1.2 Diagnostic/Clinics
5.1.3 ICUs
5.1.4 Home Healthcare
5.2 By Application - Global Diabetes Therapy and Drug Delivery Revenue & Forecasts
5.2.1 By Application - Global Diabetes Therapy and Drug Delivery Revenue, 2016-2021
5.2.2 By Application - Global Diabetes Therapy and Drug Delivery Revenue, 2022-2027
5.2.3 By Application - Global Diabetes Therapy and Drug Delivery Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Diabetes Therapy and Drug Delivery Market Size, 2021 & 2027
6.2 By Region - Global Diabetes Therapy and Drug Delivery Revenue & Forecasts
6.2.1 By Region - Global Diabetes Therapy and Drug Delivery Revenue, 2016-2021
6.2.2 By Region - Global Diabetes Therapy and Drug Delivery Revenue, 2022-2027
6.2.3 By Region - Global Diabetes Therapy and Drug Delivery Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Diabetes Therapy and Drug Delivery Revenue, 2016-2027
6.3.2 US Diabetes Therapy and Drug Delivery Market Size, 2016-2027
6.3.3 Canada Diabetes Therapy and Drug Delivery Market Size, 2016-2027
6.3.4 Mexico Diabetes Therapy and Drug Delivery Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Diabetes Therapy and Drug Delivery Revenue, 2016-2027
6.4.2 Germany Diabetes Therapy and Drug Delivery Market Size, 2016-2027
6.4.3 France Diabetes Therapy and Drug Delivery Market Size, 2016-2027
6.4.4 U.K. Diabetes Therapy and Drug Delivery Market Size, 2016-2027
6.4.5 Italy Diabetes Therapy and Drug Delivery Market Size, 2016-2027
6.4.6 Russia Diabetes Therapy and Drug Delivery Market Size, 2016-2027
6.4.7 Nordic Countries Diabetes Therapy and Drug Delivery Market Size, 2016-2027
6.4.8 Benelux Diabetes Therapy and Drug Delivery Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Diabetes Therapy and Drug Delivery Revenue, 2016-2027
6.5.2 China Diabetes Therapy and Drug Delivery Market Size, 2016-2027
6.5.3 Japan Diabetes Therapy and Drug Delivery Market Size, 2016-2027
6.5.4 South Korea Diabetes Therapy and Drug Delivery Market Size, 2016-2027
6.5.5 Southeast Asia Diabetes Therapy and Drug Delivery Market Size, 2016-2027
6.5.6 India Diabetes Therapy and Drug Delivery Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Diabetes Therapy and Drug Delivery Revenue, 2016-2027
6.6.2 Brazil Diabetes Therapy and Drug Delivery Market Size, 2016-2027
6.6.3 Argentina Diabetes Therapy and Drug Delivery Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Diabetes Therapy and Drug Delivery Revenue, 2016-2027
6.7.2 Turkey Diabetes Therapy and Drug Delivery Market Size, 2016-2027
6.7.3 Israel Diabetes Therapy and Drug Delivery Market Size, 2016-2027
6.7.4 Saudi Arabia Diabetes Therapy and Drug Delivery Market Size, 2016-2027
6.7.5 UAE Diabetes Therapy and Drug Delivery Market Size, 2016-2027
7 Players Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Corporate Summary
7.1.2 Abbott Laboratories Business Overview
7.1.3 Abbott Laboratories Diabetes Therapy and Drug Delivery Major Product Offerings
7.1.4 Abbott Laboratories Diabetes Therapy and Drug Delivery Revenue in Global (2016-2021)
7.1.5 Abbott Laboratories Key News
7.2 Medtronic
7.2.1 Medtronic Corporate Summary
7.2.2 Medtronic Business Overview
7.2.3 Medtronic Diabetes Therapy and Drug Delivery Major Product Offerings
7.2.4 Medtronic Diabetes Therapy and Drug Delivery Revenue in Global (2016-2021)
7.2.5 Medtronic Key News
7.3 Sanofi
7.3.1 Sanofi Corporate Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Diabetes Therapy and Drug Delivery Major Product Offerings
7.3.4 Sanofi Diabetes Therapy and Drug Delivery Revenue in Global (2016-2021)
7.3.5 Sanofi Key News
7.4 Novo Nordisk
7.4.1 Novo Nordisk Corporate Summary
7.4.2 Novo Nordisk Business Overview
7.4.3 Novo Nordisk Diabetes Therapy and Drug Delivery Major Product Offerings
7.4.4 Novo Nordisk Diabetes Therapy and Drug Delivery Revenue in Global (2016-2021)
7.4.5 Novo Nordisk Key News
7.5 MannKind
7.5.1 MannKind Corporate Summary
7.5.2 MannKind Business Overview
7.5.3 MannKind Diabetes Therapy and Drug Delivery Major Product Offerings
7.5.4 MannKind Diabetes Therapy and Drug Delivery Revenue in Global (2016-2021)
7.5.5 MannKind Key News
7.6 Enteris BioPharma
7.6.1 Enteris BioPharma Corporate Summary
7.6.2 Enteris BioPharma Business Overview
7.6.3 Enteris BioPharma Diabetes Therapy and Drug Delivery Major Product Offerings
7.6.4 Enteris BioPharma Diabetes Therapy and Drug Delivery Revenue in Global (2016-2021)
7.6.5 Enteris BioPharma Key News
7.7 Dexcom
7.7.1 Dexcom Corporate Summary
7.7.2 Dexcom Business Overview
7.7.3 Dexcom Diabetes Therapy and Drug Delivery Major Product Offerings
7.4.4 Dexcom Diabetes Therapy and Drug Delivery Revenue in Global (2016-2021)
7.7.5 Dexcom Key News
7.8 Senseonics Holding
7.8.1 Senseonics Holding Corporate Summary
7.8.2 Senseonics Holding Business Overview
7.8.3 Senseonics Holding Diabetes Therapy and Drug Delivery Major Product Offerings
7.8.4 Senseonics Holding Diabetes Therapy and Drug Delivery Revenue in Global (2016-2021)
7.8.5 Senseonics Holding Key News
7.9 Medtech
7.9.1 Medtech Corporate Summary
7.9.2 Medtech Business Overview
7.9.3 Medtech Diabetes Therapy and Drug Delivery Major Product Offerings
7.9.4 Medtech Diabetes Therapy and Drug Delivery Revenue in Global (2016-2021)
7.9.5 Medtech Key News
7.10 Johnson & Johnson
7.10.1 Johnson & Johnson Corporate Summary
7.10.2 Johnson & Johnson Business Overview
7.10.3 Johnson & Johnson Diabetes Therapy and Drug Delivery Major Product Offerings
7.10.4 Johnson & Johnson Diabetes Therapy and Drug Delivery Revenue in Global (2016-2021)
7.10.5 Johnson & Johnson Key News
7.11 Synertech
7.11.1 Synertech Corporate Summary
7.11.2 Synertech Business Overview
7.11.3 Synertech Diabetes Therapy and Drug Delivery Major Product Offerings
7.11.4 Synertech Diabetes Therapy and Drug Delivery Revenue in Global (2016-2021)
7.11.5 Synertech Key News
7.12 Zosano Pharma
7.12.1 Zosano Pharma Corporate Summary
7.12.2 Zosano Pharma Business Overview
7.12.3 Zosano Pharma Diabetes Therapy and Drug Delivery Major Product Offerings
7.12.4 Zosano Pharma Diabetes Therapy and Drug Delivery Revenue in Global (2016-2021)
7.12.5 Zosano Pharma Key News
7.13 Relmada Therapeutics
7.13.1 Relmada Therapeutics Corporate Summary
7.13.2 Relmada Therapeutics Business Overview
7.13.3 Relmada Therapeutics Diabetes Therapy and Drug Delivery Major Product Offerings
7.13.4 Relmada Therapeutics Diabetes Therapy and Drug Delivery Revenue in Global (2016-2021)
7.13.5 Relmada Therapeutics Key News
7.14 Eli Lilly
7.14.1 Eli Lilly Corporate Summary
7.14.2 Eli Lilly Business Overview
7.14.3 Eli Lilly Diabetes Therapy and Drug Delivery Major Product Offerings
7.14.4 Eli Lilly Diabetes Therapy and Drug Delivery Revenue in Global (2016-2021)
7.14.5 Eli Lilly Key News
7.15 Transdermal Specialties
7.15.1 Transdermal Specialties Corporate Summary
7.15.2 Transdermal Specialties Business Overview
7.15.3 Transdermal Specialties Diabetes Therapy and Drug Delivery Major Product Offerings
7.15.4 Transdermal Specialties Diabetes Therapy and Drug Delivery Revenue in Global (2016-2021)
7.15.5 Transdermal Specialties Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Diabetes Therapy and Drug Delivery Market Opportunities & Trends in Global Market
Table 2. Diabetes Therapy and Drug Delivery Market Drivers in Global Market
Table 3. Diabetes Therapy and Drug Delivery Market Restraints in Global Market
Table 4. Key Players of Diabetes Therapy and Drug Delivery in Global Market
Table 5. Top Diabetes Therapy and Drug Delivery Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Diabetes Therapy and Drug Delivery Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Diabetes Therapy and Drug Delivery Revenue Share by Companies, 2016-2021
Table 8. Global Companies Diabetes Therapy and Drug Delivery Product Type
Table 9. List of Global Tier 1 Diabetes Therapy and Drug Delivery Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Diabetes Therapy and Drug Delivery Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type